Request appointment
1300 York AvenueNew York, NY 10021
Overview of Dr. Mulvey
Lymphoma Program
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2018 - 2021
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2015 - 2018
New York Medical CollegeClass of 2015
Certifications & Licensure
NY State Medical License 2018 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsCell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma.Edward R Scheffer Cliff, Guido D Pelaez, Fei Wan, Varun Iyengar, Jihao Zhou
Clinical Cancer Research. 2026-01-06 - Patient preferences for attributes of bispecific antibodies for relapse/refractory diffuse large B-cell lymphoma in the US.Erin Mulvey, Jason Shafrin, Kyi-Sin Than, Sanjana Muthukrishnan, Alex Mutebi
Future Oncology. 2025-11-01 - 5 citationsThe future of follicular lymphoma management: strategies on the horizon.Erin Mulvey, Sarah C Rutherford, John P Leonard
Blood. 2025-10-09
Press Mentions
Lymphoma Research Foundation Funds 29 Grants Investigating Lymphoma and Chronic Lymphocytic Leukemia, Introduces Expanded Research Program and Health Equity InitiativeMarch 31st, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
